AnaptysBio Inc.

NASDAQ: ANAB · Real-Time Price · USD
20.05
-0.10 (-0.50%)
At close: Aug 20, 2025, 3:59 PM

AnaptysBio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-132.59M -140.62M -145.23M -165.66M -170.12M -163.3M -163.62M -147.82M -144.01M -136.72M -128.72M -134.85M -108.01M -75.89M -57.8M 8.39M -8.71M -29.83M
Depreciation & Amortization
2.4M 2.4M 2.4M 2.4M 2.4M 2.39M 2.38M 2.38M 2.37M 2.35M 2.33M 2.11M 2.2M 2.54M 2.09M 1.85M 1.32M 544K
Stock-Based Compensation
34.78M 33.09M 34.05M 33.98M 33.59M 34.48M 33.2M 31.78M 30.24M 28.47M 27.36M 24.65M 22.74M 19.77M 15.35M 14.35M 12.79M 11.84M
Other Working Capital
-7M -764K -6.37M -3.79M -3.16M -7.48M -5.83M -6.94M 1.72M -1.08M -2.32M 3.01M -4.58M -1.29M 372.94M 371.31M 376.03M 741.63M
Other Non-Cash Items
74.04M 64.84M 61.61M 51.47M 40.6M 26.91M 15.89M 13.46M 14.38M 15.73M 18.6M 17.62M 12.36M 6.78M 1.93M 626K 719K 662K
Deferred Income Tax
n/a n/a n/a -3.15M -6.15M -8.33M -8.33M -5.18M -2.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-97.1M -58.91M -68.78M -2.66M -10.34M -15.81M -324K 8.24M 20.79M 13.02M 6.84M 2.25M -6.75M 3.07M -7.49M -8.25M 840K -5.46M
Operating Cash Flow
-127.71M -101.84M -135.34M -103.01M -129.4M -140.43M -120.8M -97.14M -78.41M -77.15M -73.59M -88.21M -77.47M -43.73M -45.92M 16.96M 6.95M -22.25M
Capital Expenditures
-372K -366K -358K -375K -502K -659K -807K -702K -590K -478K -358K -197K -319K -1.1M -1.37M -1.66M -1.58M -799K
Cash Acquisitions
n/a n/a n/a -49.46M -80.25M -59.99M -145.56M -117.78M -54.59M -3.94M 81.63M 104.68M 72.31M 1.4M 7.63M 201.18M 201.16M 201.16M
Purchase of Investments
-348.98M -443.93M -380.38M -325.8M -344.5M -314.36M -303.92M -365.19M -475.27M -528.58M -802.5M -767.11M -603.72M -434.9M -118.66M -64.84M -117.71M -127.15M
Sales Maturities Of Investments
429.83M 485.92M 476.13M 500.15M 490.99M 442.99M 449.48M 482.96M 529.87M 532.52M 408.02M 284.27M 164.26M 105.18M 158.85M 175.61M 222.31M 268.4M
Other Investing Acitivies
n/a -2.41M 66.23M 115.69M 146.49M 128.63M 145.56M 117.78M 54.59M 3.94M -394.49M -417.54M -385.14M -275.4M 31.22M -162.33M -157.52M -120.87M
Investing Cash Flow
80.47M 41.63M 95.4M 173.97M 145.99M 127.97M 144.75M 117.07M 54M 3.46M -394.85M -483.04M -439.76M -330.81M 38.84M 109.13M 103.02M 140.45M
Debt Repayment
-27.72M 7.07M 7.07M 7.07M 33.97M -1.8M -3.07M -3.07M -3.07M -1.27M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-55.98M -4.88M -456K n/a n/a -12.47M -50M -50M -50M -37.53M n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.64M 2.64M 12.65M -20.24M -23.1M -23.1M -8.7M -4.75M 32.81M 32.38M 32.19M 285M 250.67M 251.1M 251.34M 126K 389K 460K
Financial Cash Flow
19.71M 105.16M 127.05M 94.33M 20.03M -28.42M -59.3M -52.19M -12.09M 1.83M 44.02M 293.4M 256.62M 256.74M 252.3M 1.09M 1.11M 627K
Net Cash Flow
-27.52M 44.94M 87.11M 165.29M 36.62M -40.87M -35.34M -32.25M -36.49M -71.85M -424.42M -277.84M -260.61M -117.8M 245.21M 127.17M 111.08M 118.83M
Free Cash Flow
-128.08M -102.21M -135.69M -103.39M -129.9M -141.08M -121.61M -97.84M -79M -77.63M -73.95M -88.41M -77.79M -44.83M -47.29M 15.3M 5.37M -23.05M